Purpose
To investigate a new human leukocyte antigen E (HLA-E) T cell based vaccine platform to support the development of improved vaccines for HPV and HIV, which adversely affect the world’s poorest populations.
Grantee
Division
Global Health
Date
NOVEMBER 2024
Region served
GLOBAL
Committed amount
$4,997,835
Grant topic
Discovery and Translational Sciences,
HIV
Duration (months)
23
Grantee location
La Jolla, CA, United States
Program strategy page
More about our work
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.